Patents by Inventor Justin Warner

Justin Warner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090114666
    Abstract: A laundry vacuum transfer system comprising a stock box (12 or 13), having an inlet (22) connectable to a passageway and an outlet (23) connectable to a vacuum means (24) for developing sub-atmospheric pressure within the box and along the passageway for drawing textile articles into the box via said inlet, the box having an upper door (27) dividing the box into upper and lower compartments (31,32) and a lower door (28) for controlling discharge of textile articles onto a compartmentalized transfer belt (15) located beneath the lower door (28)), and an accumulation bin (16 or 17) which receives laundry from the transfer belt (15), which is indexed to transport the laundry to the bin (16 or 17), the stock box having both compartments separately connected to the outlet via valve means (29).
    Type: Application
    Filed: November 3, 2007
    Publication date: May 7, 2009
    Inventors: James Christopher Thorpe, Richard Wesley Thrift, Mark Justin Warner
  • Publication number: 20080009076
    Abstract: The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL-4 induced processes associated therewith, methods and kits for identifying such compounds that utilize a thioredoxin-like 32 kDa protein (TXNL) as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts.
    Type: Application
    Filed: December 8, 2006
    Publication date: January 10, 2008
    Applicant: Rigel Pharmaceuticals, Inc.
    Inventors: Esteban Masuda, Todd Kinsella, Justin Warner, Taisei Kinoshita, Mark Bennett, David Anderson
  • Publication number: 20080003618
    Abstract: The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL-4 induced processes associated therewith, methods and kits for identifying such compounds that utilize a BAP-37 as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts.
    Type: Application
    Filed: December 8, 2006
    Publication date: January 3, 2008
    Applicant: Rigel Pharmaceuticals, Inc.
    Inventors: Esteban MASUDA, Todd Kinsella, Justin Warner, Taisei Kinoshita, Mark Bennett, David Anderson
  • Publication number: 20080003620
    Abstract: The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL-4 induced processes associated therewith, methods and kits for identifying such compounds that utilize an adenosine kinase as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts.
    Type: Application
    Filed: December 8, 2006
    Publication date: January 3, 2008
    Applicant: Rigel Pharmaceuticals, Inc.
    Inventors: Esteban Masuda, Todd Kinsella, Justin Warner, Taisei Kinoshita, Mark Bennett, David Anderson
  • Publication number: 20070298440
    Abstract: The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL-4 induced processes associated therewith, methods and kits for identifying such compounds that utilize a retinoid X receptor as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts.
    Type: Application
    Filed: December 8, 2006
    Publication date: December 27, 2007
    Applicant: Rigel Pharmaceuticals, Inc.
    Inventors: Todd Kinsella, Esteban Masuda, Mark Bennett, Justin Warner, David Anderson
  • Publication number: 20070298437
    Abstract: The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL-4 induced processes associated therewith, methods and kits for identifying such compounds that utilize a chloride intracellular channel 1 (CLIC1) as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts.
    Type: Application
    Filed: December 8, 2006
    Publication date: December 27, 2007
    Applicant: Rigel Pharmaceuticals, Inc.
    Inventors: Esteban Masuda, Todd Kinsella, Justin Warner, Taisei Kinoshita, Mark Bennett, David Anderson
  • Publication number: 20070244033
    Abstract: The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL-4 induced processes associated therewith, methods and kits for identifying such compounds that utilize a c-Myc protein as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts.
    Type: Application
    Filed: December 8, 2006
    Publication date: October 18, 2007
    Applicant: Rigel Pharmaceuticals, Inc.
    Inventors: Esteban MASUDA, Todd Kinsella, Justin Warner, Taisei Kinoshita, Mark Bennett, David Anderson
  • Publication number: 20070135350
    Abstract: The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL-4 induced processes associated therewith, methods and kits for identifying such compounds that utilize a BAP-37 as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts.
    Type: Application
    Filed: February 20, 2007
    Publication date: June 14, 2007
    Applicant: Rigel Pharmaceuticals, Inc.
    Inventors: Esteban Masuda, Todd Kinsella, Justin Warner, Taisei Kinoshita, Mark Bennett, David Anderson
  • Publication number: 20070054862
    Abstract: The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL-4 induced processes associated therewith, methods and kits for identifying such compounds that utilize an adenosine kinase as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts.
    Type: Application
    Filed: October 18, 2006
    Publication date: March 8, 2007
    Applicant: Rigel Pharmaceuticals, Inc.
    Inventors: Esteban Masuda, Todd Kinsella, Justin Warner, Taisei Kinoshita, Mark Bennett, David Anderson
  • Publication number: 20050112702
    Abstract: The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL-4 induced processes associated therewith, methods and kits for identifying such compounds that utilize a CLLD8 protein as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts.
    Type: Application
    Filed: December 30, 2004
    Publication date: May 26, 2005
    Applicant: Rigel Pharmaceuticals, Inc.
    Inventors: Esteban Masuda, Todd Kinsella, Justin Warner, Taisei Kinoshita, Mark Bennett, David Anderson